A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT06716138 · RECRUITING

Trial details

NCT number: NCT06716138
Sponsor: Avistone Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration

Start date: 2025-03-06
Primary completion: 2027-12-30
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.